Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-derived Exosomes for Decompensated Liver Cirrhosis
NCT05871463Phase 2Unknown
- Sponsor
- Research Institute for Gastroenterology and Liver Diseases
- Start
- May 2023
- Primary completion
- Aug 2023
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord derived mesenchymal stem cells exosomes in Liver cirrhosis (LC), sponsored by Research Institute for Gastroenterology and Liver Diseases. Status: unknown.
02
Drugs
umbilical cord derived mesenchymal stem cells exosomes
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT05871463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05871463.